Division of Pediatric Infectious Diseases, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
Division of Neonatal Medicine, Department of Pediatric and Adolescent Medicine, Mayo Clinic, Rochester, Minnesota
Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology; and, Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota
Supported by the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, MN, through a Collaborative Award.
R.P. reports grants from CD Diagnostics, BioFire, Curetis, Merck, Contrafect, Hutchison Biofilm Medical Solutions, Accelerate Diagnostics, Allergan, EnBiotix, Contrafect, and The Medicines Company. She is or has been a consultant to Curetis, Specific Technologies, Selux Dx, GenMark Diagnostics, PathoQuest, Heraeus Medical, and Qvella; monies are paid to Mayo Clinic. In addition, she has a patent on Bordetella pertussis/parapertussis polymerase chain reaction issued, a patent on a device/method for sonication with royalties paid by Samsung to Mayo Clinic and a patent on an antibiofilm substance issued. She receives travel reimbursement from American Society for Microbiology and Infectious Diseases Society of America and an editor’s stipend from American Society for Microbiology and Infectious Diseases Society of America, and honoraria from the National Board of Medical Examiners, Up-to-Date and the Infectious Diseases Board Review Course. All other authors have no conflicts of interest to disclose.
Address for correspondence: Robin Patel, MD, Division of Clinical Microbiology, Mayo Clinic, Rochester, MN 55905. E-mail: email@example.com.